Sumitomo Pharma Switzerland GmbH clinical trials
Acquired by Sumitomo Pharma Co., Ltd., Dec 27, 2019 · source ↗
The registry lists 15 studies whose lead sponsor is Sumitomo Pharma Switzerland GmbH. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 13, 2026.
Before and after it joined Sumitomo Pharma Co., Ltd.
- First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- 10
- First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- 5
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Sumitomo Pharma Switzerland GmbH15 studies
Something wrong with this grouping? Tell us on the Sumitomo Pharma Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 15 of 15. All Sumitomo Pharma Co., Ltd. studies →
- Congenital Athymia Patient RegistryRecruitingNCT05329935
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their OffspringRecruitingNCT05739123
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisRecruitingNCT05862272Phase 3
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for PregnancyCompletedNCT04756037Phase 3
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination TherapyActive, not recruitingNCT05739136
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted after Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Thymus Transplantation Safety-EfficacyCompletedNCT01220531Not applicable
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Expanded Access Protocol Thymus TransplantationCompletedNCT02274662Phase 4
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Thymus Transplantation With ImmunosuppressionCompletedNCT00579709Phase 1
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Parathyroid and Thymus Transplantation in DiGeorge #931CompletedNCT00566488Phase 1
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus TransplantationTerminatedNCT00597441Phase 1
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Serum-Free Thymus Transplantation in DiGeorge AnomalyTerminatedNCT00849888Phase 1
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Phase I/II Thymus Transplantation With Immunosuppression #950CompletedNCT00579527Phase 1/2
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Thymus Transplantation Dose in DiGeorge #932CompletedNCT00576836Phase 2
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Thymus Transplantation in DiGeorge Syndrome #668CompletedNCT00576407Phase 2
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.
- Farber Disease Natural History StudyCompletedNCT03233841
Sponsor listed in the registry: Sumitomo Pharma Switzerland GmbH · First submitted before Sumitomo Pharma Switzerland GmbH became part of Sumitomo Pharma Co., Ltd.